ストックスクリーナーアプリを入手
6.73
0.30%
0.02
アフターアワーズ：
6.73
前日終値:
$6.71
開ける：
$6.69
24時間の取引高:
45,552
Relative Volume:
0.58
時価総額：
$386.92M
収益：
$154.57M
当期純損益:
$15.07M
株価収益率:
24.93
EPS:
0.27
ネットキャッシュフロー:
$10.92M
1週間 パフォーマンス:
-6.40%
1か月 パフォーマンス:
+10.51%
6か月 パフォーマンス:
+19.12%
1年 パフォーマンス:
+17.45%
1日の値動き範囲:
$6.675
$6.83
1週間の範囲:
$6.675
$6.9898
52週間の値動き範囲:
$4.74
$8.00
Kamada Ltd Stock (KMDA) Company Profile
KMDA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
6.73 | 386.92M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
170.90 | 77.10B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.47 | 42.82B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.39 | 42.45B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.73 | 20.09B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
151.82 | 15.37B | 2.24B | 385.90M | 440.10M | 3.73 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-03 | 開始されました | Stifel | Buy |
| 2018-02-02 | 開始されました | Chardan Capital Markets | Buy |
Kamada Ltd (KMDA) 最新ニュース
Kamada Ltd. (NASDAQ:KMDA) Short Interest Up 33.3% in January - MarketBeat
High Growth Tech Stocks To Watch In January 2025 - Simply Wall St
Kamada to supply immune globulin products in Latin America - Pharmaceutical Business Review
Kamada secures $25 million Latin America contract - MSN
Kamada Secures $25 Million Contract for Immune Globulin Products in Latin America - TipRanks
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America - The Manila Times
Kamada Secures Major $25M Contract for Life-Saving Immunoglobulin Drugs in Latin America - StockTitan
Kamada Ltd. (NASDAQ:KMDA) Short Interest Up 33.3% in December - MarketBeat
Kamada’s (KMDA) Buy Rating Reiterated at HC Wainwright - Defense World
Market Participants Recognise Kamada Ltd.'s (TLV:KMDA) Earnings Pushing Shares 25% Higher - Simply Wall St
Kamada's (KMDA) Buy Rating Reiterated at HC Wainwright - MarketBeat
Kamada Projects Double-Digit Growth for 2025, Expands Plasma Operations - Yahoo Finance
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025 - GlobeNewswire
Kamada Projects Strong 2025 Growth: 13% Revenue Jump to $182M, EBITDA to Rise 19% - StockTitan
KMDA stock touches 52-week high at $6.53 amid market optimism By Investing.com - Investing.com South Africa
Kamada (NASDAQ:KMDA) Stock Price Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat
Comparing Endonovo Therapeutics (OTCMKTS:ENDVD) & Kamada (NASDAQ:KMDA) - Defense World
KMDA stock touches 52-week high at $6.53 amid market optimism - Investing.com Australia
Financial Survey: Kamada (NASDAQ:KMDA) versus Endonovo Therapeutics (OTCMKTS:ENDVD) - Defense World
Exploring High Growth Tech Stocks This January 2025 - Yahoo Finance
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat
Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024 - The Manila Times
Exploring Undiscovered Gems with Potential This December 2024 - Simply Wall St
So who replaces Eberechi Eze against Arsenal? Crystal Palace boss asked if summer signing will step in - South London News
Music Industry Moves: Avex USA Names Ryusuke Kamada CFO - Yahoo Entertainment
Kamada Ltd. Approves Board Re-Elections and Auditor Appointment - TipRanks
Gauzy Appoints Lilach Payorski to Board - Glass Magazine
Gauzy Adds to Board of Directors - CleanLink
Here's Why Shareholders May Want To Be Cautious With Increasing Kamada Ltd.'s (TLV:KMDA) CEO Pay Packet - Simply Wall St
Short Interest in Kamada Ltd. (NASDAQ:KMDA) Expands By 8.9% - Defense World
Gauzy Appoints Seasoned Public Company Executive and Director Lilach Payorski to Board of Directors - The Manila Times
Gauzy Strengthens Board with Ex-Stratasys CFO Lilach Payorski as Audit Chair | GAUZ Stock News - StockTitan
Maxkamada Banaadir oo soo saartay Waaran lagu soo xirayo Madaxweynaha Jubaland - Horseed Media
Solid Earnings Reflect Kamada's (TLV:KMDA) Strength As A Business - Simply Wall St
Alpha 1 Antitrypsin Deficiency Treatment Market Analysis By Top - openPR
HC Wainwright Issues Pessimistic Outlook for Kamada Earnings - MarketBeat
What is HC Wainwright’s Forecast for Kamada FY2024 Earnings? - Defense World
Alpha-1 Antitrypsin Deficiency Therapy Market 2024-2031 - openPR
HC Wainwright Forecasts Kamada's Q4 Earnings (NASDAQ:KMDA) - MarketBeat
Earnings call: Kamada Ltd. reports growth and raises EBITDA outlook - Investing.com India
Phoenix Financial Ltd. Increases Stake in Kamada Ltd. - GuruFocus.com
Kamada Ltd. (NASDAQ:KMDA) Q3 2024 Earnings Call Transcript - Insider Monkey
Kamada Ltd (KMDA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Increased EBITDA ... - Yahoo Finance
Kamada Ltd (KMDA) Q3 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Type 1 Alpha-1 Antitrypsin Deficiency Treatment Market to Grow - openPR
Alpha-1 Antitrypsin Deficiency Market Expected to Experience Major Growth by 2034, According to DelveInsight | Kamada Pharma, Mereo BioPharma/AstraZeneca, Grifols Therapeutics LLC, Takeda, Vertex - Barchart
Earnings call: Kamada Ltd. reports growth and raises EBITDA outlook By Investing.com - Investing.com Australia
Kamada Ltd (KMDA) 財務データ
収益
当期純利益
現金流量
EPS
1.19%
0.06%
大文字化:
|
ボリューム (24 時間):